Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services, and its news flow reflects this focus on out‑of‑facility care. Company press releases highlight developments in its mobile health services, remote patient monitoring, ambulance and medical transport operations, and its 50‑state virtual care network.
Investors following DocGo news can expect regular updates on financial results, including quarterly earnings announcements furnished on Form 8‑K, where the company discusses segment performance for Mobile Health Services and Transportation Services, adjusted gross margin metrics and adjusted EBITDA. These releases often include commentary from management on contract activity, care gap closure volumes, and the evolution of its payer and provider relationships.
DocGo’s news also covers contract wins and program launches, such as care gap closure programs with insurance providers, population health initiatives with public health plans and tribal and state health departments, vaccination programs with counties, and multi‑year ambulance contracts with academic medical systems and municipalities. Announcements describing longitudinal care services and transitions of care programs illustrate how the company uses mobile clinicians and telehealth to engage patients at home.
Another recurring theme in DocGo news is strategic activity and capital allocation. The company has issued releases and filed 8‑Ks regarding the acquisition of virtual care platform SteadyMD, as well as updates on its share repurchase program. In addition, DocGo frequently announces participation in healthcare and growth investor conferences, providing insight into how management presents its strategy to the market.
For anyone tracking DCGO, this news page aggregates these earnings releases, contract announcements, program launches, acquisition updates and conference appearances in one place, offering a consolidated view of the company’s operational and strategic milestones over time.
DocGo (Nasdaq: DCGO) was named one of Ethisphere’s 2026 World’s Most Ethical Companies®, its first time receiving the honor. DocGo is one of four honorees in the healthcare providers and services category; 138 organizations across 17 countries and 40 industries were recognized in 2026.
The recognition cites DocGo’s governance, compliance, training, confidential reporting channels, and its use of Ethisphere’s Ethics Quotient®, which evaluates 240+ documented proof points.
DocGo (Nasdaq: DCGO) reported Q4 and full-year 2025 results and raised 2026 guidance after customer expansions and efficiency gains. Q4 revenue was $74.9M (Q4 2024: $120.8M) and full-year revenue was $322.2M (2024: $616.6M), driven by wind-down of migrant-related programs. GAAP gross margin was 27.2% in Q4; adjusted EBITDA loss improved to a projected $5–$10M for 2026. The company recorded significant non-cash impairments in 2025 and acquired SteadyMD on October 20, 2025.
Summary not available.
DocGo (Nasdaq: DCGO) will release its fourth quarter and full year 2025 financial results after market close on Monday, March 16, 2026. Management will host a conference call and webcast at 5:00 p.m. ET to discuss results and the company outlook for 2026.
Investors can join by phone (U.S. 1-800-717-1738; international 1-646-307-1865) using Conference ID 74028, or listen via the webcast under Events on the company investor website.
DocGo (Nasdaq: DCGO) said CEO Lee Bienstock will attend the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 and present at 9:10 AM ET. A live webcast will be available via the company’s investor relations website.
DocGo (Nasdaq: DCGO) said its virtual care division, SteadyMD, will expand clinical staff by up to 50% over the coming weeks to meet accelerating demand for clinician-led telehealth supporting branded GLP-1 weight loss care.
The hiring targets multi-state licensed clinicians (five or more active state licenses) to support nationwide delivery and onboarding is expected to begin in the next several weeks. The move aims to scale partnerships with consumer, healthcare, and digital wellness customers, including multiple Fortune 10 brands.
DocGo (Nasdaq: DCGO) announced that Chief Financial Officer Norm Rosenberg will participate in a fireside chat at the 28th Annual Needham Growth Conference on Wednesday, January 14, 2026 at 1:30 PM ET.
Rosenberg will also take part in one-on-one investor meetings. A live webcast of the fireside chat will be available on DocGo's investor relations website at https://ir.docgo.com/.
DocGo (Nasdaq: DCGO) said management will participate in three investor conferences in December 2025: Noble Capital Markets Emerging Growth Conference on December 3, Citi 2025 Global Healthcare Conference on December 4, and iAccess Alpha Best Ideas Conference on December 9–10.
CEO Lee Bienstock will deliver presentations at Noble (Dec 3 at 1:00 PM ET) and iAccess (Dec 9 at 1:00 PM ET) and will attend 1x1 meetings at all listed events. Webcasts of the two presentations will be available on DocGo's investor relations site at https://ir.docgo.com/.
DocGo (Nasdaq: DCGO) said management will participate in four investor conferences in November 2025: the 17th Annual Southwest Ideas Conference on November 19, Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum on November 20, Needham Sixth Annual Tech Week on November 21, and the BTIG Digital Health Forum on November 24.
CFO Norm Rosenberg will present at the Southwest Ideas Conference on Nov 19 at 2:20 PM ET with a webcast available on DocGo’s investor relations site. CEO Lee Bienstock and CFO Norm Rosenberg are scheduled for 1x1 meetings at the Canaccord and Needham events. CEO Bienstock will join a BTIG panel on Care Gap Closure and Mobile Health Support at 11:00 AM ET on Nov 24.
DocGo (Nasdaq: DCGO) reported third quarter 2025 results with total revenue $70.8M, down from $138.7M a year ago due to the wind-down of migrant-related programs.
Excluding migrant-related revenue, core revenue rose 8% to $62.4M. GAAP gross margin was 20.0% and adjusted gross margin was 33.0%. Net loss was $29.7M, which included $16.7M of non-cash impairments. Adjusted EBITDA loss was $7.2M. Cash and equivalents were $95.2M as of Sept 30, 2025, after repaying a $30M line of credit; operating cash flow was $1.7M for the quarter.
Company reported record volumes across major lines (transportation +2.5%, care gap +320%, phlebotomy +11%, RPM +6%), completed the acquisition of SteadyMD, and provided 2025 and 2026 guidance: 2025 revenue $315–320M (including $68–70M migrant revenue) and adjusted EBITDA loss $25–28M; 2026 revenue $280–300M with adjusted EBITDA loss $15–25M.